Related Experiment Video
Updated: Aug 15, 2025

HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice
Published on: July 9, 2016
SnapShot: Psychedelics and serotonin receptor signaling
Ryan H Gumpper1, Bryan L Roth1
1University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599-7365, USA.
Psychedelics, which target the serotonin (5-hydroxytryptamine; 5HT) 5HT2A receptor, show promise as novel therapeutics for neuropsychiatric disorders. This research explores their potential to transform treatments for these complex conditions.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Serotonin (5-hydroxytryptamine; 5HT) is a key neurotransmitter regulating numerous physiological and behavioral processes.
- Dysregulation of 5HT signaling is implicated in various neuropsychiatric disorders.
Purpose of the Study:
- To investigate the therapeutic potential of psychedelics targeting the 5HT2A receptor.
- To explore novel treatment strategies for neuropsychiatric conditions.
Main Methods:
- Review of existing literature on serotonin signaling and psychedelic pharmacology.
- Analysis of the role of the 5HT2A receptor in neuropsychiatric disorders.
Main Results:
- Psychedelics demonstrate a specific affinity for the 5HT2A receptor.
- This interaction suggests a mechanism for their therapeutic effects.
Conclusions:
- Targeting the 5HT2A receptor with psychedelics represents a promising avenue for developing transformative therapies.
- Further research is warranted to fully elucidate their clinical applications.
More Related Videos
Related Concept Videos
CNS Stimulants: Psychedelic Agents
Hallucinogens and Psychedelics
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
G-protein Coupled Receptors
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Antidepressant Drugs: MAOIs and Other Agents

